Title : Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.

Pub. Date : 2001 Jul

PMID : 11699407






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In cells treated with OL(1) p53 and Idarubicin, truncated p53 message of a predicted 201 base pair length based on RNAase H cleavage of the OL(1) p53-p53 mRNA heteroduplex was detected after 7 hours of incubation. Idarubicin tumor protein p53 Homo sapiens
2 In cells treated with OL(1) p53 and Idarubicin, truncated p53 message of a predicted 201 base pair length based on RNAase H cleavage of the OL(1) p53-p53 mRNA heteroduplex was detected after 7 hours of incubation. Idarubicin tumor protein p53 Homo sapiens
3 In cells treated with OL(1) p53 and Idarubicin, truncated p53 message of a predicted 201 base pair length based on RNAase H cleavage of the OL(1) p53-p53 mRNA heteroduplex was detected after 7 hours of incubation. Idarubicin tumor protein p53 Homo sapiens
4 Therefore, synergistic cytotoxicity of Idarubicin for lymphoma cells treated with an oligonucleotide targeting p53 message was demonstrated at oligonucleotide and Idarubicin concentrations which were minimally toxic to hematopoietic progenitor cells. Idarubicin tumor protein p53 Homo sapiens
5 Therefore, synergistic cytotoxicity of Idarubicin for lymphoma cells treated with an oligonucleotide targeting p53 message was demonstrated at oligonucleotide and Idarubicin concentrations which were minimally toxic to hematopoietic progenitor cells. Idarubicin tumor protein p53 Homo sapiens